DB Biotech, a.s.
Slovakia SK-MF-000051838 Last updated 17 Sep 2026
- Devices
- 278
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
Anti-Giardin α-1 Ref DB 319-0.1
Anti-Synaptophysin Ref DB 156-0.1
Anti-EMA (CD227, Mucin-1) Ref DB 048-RTU-7
Anti-Human IgG Ref DB 174-RTU-15
Anti-Napsin A Ref DB 262-1
Anti-b-actin Ref DB 001-IHC-RTU-15
Anti-CD117 Ref DB 062-0.2
Anti-CD163 Ref DB 045-RTU-15
Anti-CD8 Ref DB 085-RTU-15
Anti-Annexin A1 Ref DB 266-RTU-7
Anti-Cytokeratin 20 Ref DB 119-RTU-7
Anti-Human Lambda Light Chain Ref DB 039-1
Anti-EMA (CD227, Mucin-1) Ref DB 048-0.1
Anti-Cytokeratin 16 Ref DB 100-RTU-7
Anti-CD163 Ref DB 045-0.1
Anti-Giardin α-1 Ref DB 319-RTU-7
Anti-Cytokeratin 5/6 Ref DB 097-1
Anti-CD3 Ref DB 082-RTU-15
Anti-Cytokeratin 14 Ref DB 099-1
Anti-Human Kappa Light Chain Ref DB 038-RTU-15
Anti-CD21 Ref DB 213-RTU-15
Anti-Cytokeratin 14 Ref DB 099-0.2
Anti-p53 Ref DB 026-RTU-7
Anti-Napsin A Ref DB 262-0.1
Anti-PLAP (Placental Alkaline Phosphatase) Ref DB 047-1
Anti-EMA (CD227, Mucin-1) Ref DB 048-1
Anti-Cadherin1 (E-cadherin, CD324) Ref DB 265-RTU-7
Anti-ER (Estrogen Receptor) Ref DB 053-RTU-15
Showing 251-278 of 278
About
Antibodies specially developed for IHC, WB and flow cytometry application. All rabbit clonal antibodies are developed by a novel and proprietary in-vitro cloning technology which has been developed and perfected by the DB Biotech scientific team.
What DB Biotech, a.s. makes
DB Biotech produces monoclonal antibodies targeting specific antigens for use in immunohistochemistry (IHC), Western blotting (WB), and flow cytometry. These include Anti-EBV/LMP-1, Anti-CD21, Anti-EGFR, Anti-Chromogranin A, Anti-Human Kappa Light Chain, Anti-EMA (CD227/Mucin-1), Anti-PSA, Anti-CD7, Anti-Human IgG, and Anti-CD8. The antibodies are designed for diagnostic applications in laboratory settings.
The company’s antibody portfolio is classified under EU medical device regulations as Class A and Class C, with devices registered in the EU’s eudamed database. DB Biotech is based in Slovakia.
Frequently asked questions
What types of medical devices does DB Biotech, a.s. manufacture?
DB Biotech, a.s. specializes in producing monoclonal antibodies designed for diagnostic use. These antibodies target specific antigens such as EBV/LMP-1, CD21, EGFR, Chromogranin A, and others, and are intended for applications like immunohistochemistry (IHC), Western blotting (WB), and flow cytometry. These products are developed to assist in laboratory-based diagnostic testing.
Where is DB Biotech, a.s. based?
DB Biotech, a.s. is headquartered in Slovakia. The company’s location is relevant for regulatory compliance, as it operates within the EU’s medical device framework, including registration in the eudamed database.
Which regulatory registries list DB Biotech’s devices?
DB Biotech’s medical devices are listed in the eudamed database, which is the official EU registry for medical devices. This registry ensures transparency and traceability of devices authorized under EU medical device regulations.
How are DB Biotech’s devices classified under EU regulations?
DB Biotech’s monoclonal antibodies fall under Class A and Class C classifications in the EU’s medical device regulatory framework. The classification depends on factors like the intended use, risk associated with the device, and the clinical significance of the diagnostic result. Class C devices are typically higher-risk diagnostic products, while Class A devices pose minimal risk.
Information
- Country
- Slovakia
- Address
- 80, Popradská, Košice, Slovakia
- Website
- www.dbbiotech.com
- [email protected]
- PRRC contact
- Martina Maďarová
- EUDAMED SRN
- SK-MF-000051838